The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 123.40% this year. Over the last six months, there has been a weaker performance of 99.37%. The price of ATYR fallen by 4.65% during the last 30 days period. For the last 5-days stocks have slided -0.63%.
Atyr Pharma Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $3.80 on 11/13/24, and the lowest price during the same period was recorded at $1.22 on 12/21/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of ATYR Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Atyr Pharma Inc’s current trading price is -17.11% away from its 52-week high, while its distance from the 52-week low is 158.20%. The stock’s price range for this period has been between $1.22 and $3.80. The Healthcare sector company’s shares saw a trading volume of about 1.14 million for the day, which was higher than the average daily volume of 0.96 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Atyr Pharma Inc (ATYR) has experienced a quarterly rise of 68.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 264.42M and boasts a workforce of 59 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.47, with a change in price of +1.03. Similarly, Atyr Pharma Inc recorded 734,502 in trading volume during the last 100 days, posting a change of +48.58%.
ATYR’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ATYR stands at 0.21. Similarly, the long-term debt-to-equity ratio is also 0.19.
ATYR Stock Stochastic Average
As of today, the raw stochastic average of Atyr Pharma Inc over the last 50 days is at 64.48%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 30.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 23.86% and 22.85%, respectively.
